EWA
DXCM icon

Evolution Wealth Advisors’s DexCom DXCM Stock Holding History

Evolution Wealth Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-392
Closed -$54K – 290
2021
Q3 		$54K Sell
392
-44
-10% -$5.55K 0.01% 201
2021
Q2 		$47K Buy
436
+104
+31% +$9.99K 0.01% 217
2021
Q1 		$30K Buy
332
+116
+54% +$10.9K 0.01% 245
2020
Q4 		$20K Buy
216
+92
+74% +$8.21K ﹤0.01% 264
2020
Q3 		$13K Hold
124
– – ﹤0.01% 319
2020
Q2 		$13K Sell
124
-80
-39% -$7.16K ﹤0.01% 252
2020
Q1 		$14K Sell
204
-24
-11% -$1.49K 0.01% 181
2019
Q4 		$12K Sell
228
-64
-22% -$3.04K ﹤0.01% 269
2019
Q3 		$11K Sell
292
-36
-11% -$1.4K 0.01% 155
2019
Q2 		$12K Buy
+328
New +$10.3K 0.01% 161

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Evolution Wealth Advisors's DXCM Position: Q4 2021 in Review

Evolution Wealth Advisors sold out of DexCom (DXCM) in Q4 2021, closing a stake of 392 shares — an estimated $54K sold.

Evolution Wealth Advisors first reported a position in DXCM in Q2 2019 and held it in 10 quarters. The position peaked at $54K in Q3 2021. 931 funds tracked by Wall St. Rank hold DXCM as of Q4 2021.

  • Evolution Wealth Advisors reported no remaining DexCom position as of Q4 2021 after selling out during the quarter.
  • Evolution Wealth Advisors sold 392 DexCom shares in Q4 2021, an estimated $54K.
  • Evolution Wealth Advisors first reported a position in DexCom in Q2 2019 and held it in 10 quarters.
  • Evolution Wealth Advisors's DexCom position peaked at $54K in Q3 2021.
  • 931 funds tracked by Wall St. Rank held DexCom as of Q4 2021.

Based on Evolution Wealth Advisors's 13F filing for Q4 2021, filed 28 Jan 2022.